Day 2 (May 25) of the Personalized Medicine World Conference (PMWC) 2017 at Duke began with a panel discussion of “The Value of Data Sharing,” moderated by conference co-chair Geoff Ginsburg, MD, PhD, Professor of Medicine and Director of the Duke Center for Applied Genomic and Precision Medicine. The distinguished panelists were Kathy Giusti, MBA, a multiple myeloma patient and founder of the Multiple Myeloma Research Foundation (MMRF) in 1998, and Faculty Co-Chair of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator--this $20M program is endowed by Robert Kraft and the Kraft Family Foundation and its mission is to speed precision medicine across all cancers; Bill Dalton (photo), MD, PhD, CEO of M2Gen, a health informatics solutions company that seeks to accelerate the discovery, development, and delivery of personalized medicine—the company was founded was founded in 2006 at the Moffitt Cancer Center in Tampa, Florida to operationalize the Total Cancer Care® Protocol, a unique approach to studying patients throughout their lifetime--in this effort, the company partners with the nation’s leading cancer centers via the Oncology Research Information Exchange Network (ORIEN)--Dr. Dalton was previously President, CEO, & Center Director of Moffitt Cancer Center--Moffitt and M2Gen have developed one of the largest cancer tumor bio-repositories and data warehouses in the U.S. dedicated to the development of personalized medicine.;Login Or Register To Read Full Story